Diabetes, prediabetes, and hyperglycemia were linked to accelerated brain aging, but physical activity and abstention from smoking and heavy drinking may mitigate much of this effect.

MH individuals with overweight or obesity showed a lower likelihood of having prediabetes than MU individuals with overweight or obesity.

Long-term exposure to fine particulate matter increased type 2 diabetes in women of childbearing age, particularly those with overweight/obesity or over 35 years of age.

Intermittent fasting reduced body weight and BMI and improved glycemic outcomes in adults with prediabetes or T2D.

Early morning hyperglycemia is sometimes called the "dawn phenomenon." Left untreated, it can drive poorer outcomes. How can it be detected and managed?

Discussions at the Advanced Technologies & Treatments for Diabetes meeting covered CGM use in non–insulin-treated people with type 2 diabetes, in prediabetes, and for diabetes diagnosis.

As diabetes cases soar in the US, physicians are sounding the alarm, especially in economically challenged regions. The push for intensive screening and proactive management has never been more critical.

Metformin plus lifestyle interventions can prevent diabetes in people with impaired glucose tolerance, treat type 2 diabetes and prediabetes, and by extension could help reduce cardiovascular disease — maybe.

New data showed considerable intrapersonal variability in fasting glucose and suggested that CGM adds important information.

Key predictors of prediabetes and diabetes after an episode of acute pancreatitis included baseline severity, elevated C-reactive protein and interleukin 6 levels, and subcutaneous fat area.

Benefits from vitamin D supplementation in kidney disease vary; routine testing is not recommended in otherwise healthy patients with chronic kidney disease.

At 3 years in SURMOUNT-1, more than 90% of people remained diabetes-free with tirzepatide and maintained their initial weight loss, but the benefits reverted after the drug was stopped.

Topline data from Lilly's SURMOUNT 1 trial shows a 94% reduction in the development of type 2 diabetes among those with prediabetes and overweight/obesity.

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

A study found that adults with metabolic syndrome and elevated blood sugar saw improvements after keeping to an 8- to 10-hour eating window.

Empagliflozin led to promising weight loss outcomes in patients with prediabetes and diabetes, with the results being more prominent in men than in women.

By itself, it's not enough, but body mass index has years of evidence behind it and still has a place in clinical assessments, experts say.

Women with a negative glucose tolerance test during pregnancy nevertheless had a high later incidence of diabetes likely due to the risk factors that triggered the test.

People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says.

Researchers believe early-onset major depressive disorder could provide a window of opportunity to mitigate increased cardiovascular disease risks associated with dyslipidemia.